These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1689914)

  • 1. The mechanism of action of FK 506.
    Kay JE; Moore AL; Doe SE; Benzie CR; Schönbrunner R; Schmid FX; Halestrap AP
    Transplant Proc; 1990 Feb; 22(1):96-9. PubMed ID: 1689914
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppression. Binding by design.
    Ringe D
    Nature; 1991 May; 351(6323):185-6. PubMed ID: 1710317
    [No Abstract]   [Full Text] [Related]  

  • 3. Is FKBP involved in the immunosuppressive and/or toxic mechanism of action of FK 506?
    Sigal NH; Dumont FJ; Siekierka JJ; Wiederrecht G; Parent SA; Brizuela L
    Transplant Proc; 1991 Dec; 23(6):2846-9. PubMed ID: 1721295
    [No Abstract]   [Full Text] [Related]  

  • 4. A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase.
    Ocain TD; Longhi D; Steffan RJ; Caccese RG; Sehgal SN
    Biochem Biophys Res Commun; 1993 May; 192(3):1340-6. PubMed ID: 7685167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK-506.
    Walliser P; Benzie CR; Kay JE
    Immunology; 1989 Nov; 68(3):434-5. PubMed ID: 2480331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FK506 as an agonist to induce inhibition of interleukin 2 production.
    Bundick RV; Donald DK; Eady RP; Hutchinson R; Keogh RW; Schmidt JA; Wells E
    Transplantation; 1992 May; 53(5):1150-3. PubMed ID: 1374947
    [No Abstract]   [Full Text] [Related]  

  • 7. Flow cytometric analysis of lymphocyte populations and activation antigen expression in blood and lymphoid tissues of FK 506-treated rats.
    Woo J; Ross CS; Milton JI; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1642-4. PubMed ID: 1697112
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression. Convergence of drug action.
    Freedman RB
    Nature; 1989 Oct; 341(6244):692. PubMed ID: 2477712
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of action of FK 506 and cyclosporin.
    Steinmann B; Superti-Furga A; Bruckner P
    Lancet; 1991 Feb; 337(8738):439. PubMed ID: 1704088
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene expression of FK 506-binding protein.
    Kar S; Carr B
    Transplant Proc; 1991 Dec; 23(6):2880-2. PubMed ID: 1721303
    [No Abstract]   [Full Text] [Related]  

  • 11. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.
    Siekierka JJ; Hung SH; Poe M; Lin CS; Sigal NH
    Nature; 1989 Oct; 341(6244):755-7. PubMed ID: 2477714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of FK 506 on B-cell responses.
    Lagodziński Z; Górski A; Stepień-Sopniewska B; Wasik M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):942-3. PubMed ID: 1703359
    [No Abstract]   [Full Text] [Related]  

  • 13. Interspecies comparison of the immunosuppressive efficacy and safety of FK 506.
    Thomson AW
    Transplant Proc; 1990 Feb; 22(1):100-5. PubMed ID: 1689883
    [No Abstract]   [Full Text] [Related]  

  • 14. Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin.
    Griffiths EJ; Halestrap AP
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):611-4. PubMed ID: 1706598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cyclolinopeptide A on T lymphocyte activation and peptidyl prolyl isomerase activity.
    Gaymes TJ; Carrett NJ; Patel N; Kay JE; Siemion IZ
    Biochem Soc Trans; 1996 Feb; 24(1):90S. PubMed ID: 8674774
    [No Abstract]   [Full Text] [Related]  

  • 17. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A.
    Flanagan WM; Corthésy B; Bram RJ; Crabtree GR
    Nature; 1991 Aug; 352(6338):803-7. PubMed ID: 1715516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine.
    Lane BC; Miller LN; Kawai M; Or YS; Wiedeman P; Holzman TF; Luly JR
    Transplant Proc; 1993 Feb; 25(1 Pt 1):644-6. PubMed ID: 7679829
    [No Abstract]   [Full Text] [Related]  

  • 20. The mechanism of action of the immunosuppressive drug FK-506.
    Kay JE; Doe SE; Benzie CR
    Cell Immunol; 1989 Nov; 124(1):175-81. PubMed ID: 2478301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.